Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisFrançois‐Clément Bidard, Paul Cottu, Mark Jesus M. Magbanua et al.|JNCI Journal of the National Cancer Institute|2018Cited by 282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Jean‐Yves Pierga et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckRicardo Hitt, Juan Jesús Cruz, Antonio Irigoyen López et al.|Annals of Oncology|2011Cited by 222
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design SimulationLorenzo Gerratana, Massimo Cristofanilli, Jean‐Yves Pierga et al.|The Oncologist|2022Cited by 13
The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “<i>indolent</i>” stage IV disease (Stage IV<sub>indolent</sub>).Andrew A. Davis, Massimo Cristofanilli, Jean‐Yves Pierga et al.|Journal of Clinical Oncology|2018Cited by 5